Latest Breaking News On - Structure therapeutics inc - Page 8 : comparemela.com

Structure Therapeutics (NASDAQ:GPCR) Shares Gap Down to $59 16

Structure Therapeutics (NASDAQ:GPCR) Shares Gap Down to $59 16
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerMonashee investment managementStructure therapeutics company profileStructure therapeutics incJefferies financial groupDriehaus capital managementStructure therapeuticsGet free reportFinancial groupCapital partnersInvestment managementCapital managementTherapeutics incStructure therapeutics daily

Five obesity-drug trends to watch in 2024

The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient.

Caroline apovianVersanis bioDamien conoverZealand pharmaNovo cagrisemaEli lillyEvan david seigermanTed kyleLilly zepboundStructure therapeutics incTherapeutics incAltimmune incPfizer incCantor fitzgeraldRoche holdingNovo nordisk

Five obesity-drug trends to watch in 2024

The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient.

Damien conoverCaroline apovianVersanis bioZealand pharmaEvan david seigermanLilly zepboundNovo cagrisemaEli lillyTed kyleAltimmune incTherapeutics incHarvard medical schoolStructure therapeutics incCantor fitzgeraldNovo nordiskPfizer inc

Phase IIa data re-Structure hopes in oral GLP-1 effort

Given what CEO Raymond Stevens called a space that’s “evolving extremely rapidly,” Structure Therapeutics Inc. chose – rather than wait for next year’s 12-week data – to unblind the eight-week obesity findings with GSBR-1290, an oral glucagon-like peptide-1 (GLP-1) agonist for which the firm also provided a phase IIa update in patients with type 2 diabetes.

Raymond stevensStructure therapeutics incGsbr 1290Structure therapeutics incGlp 1Type 2 diabetesGlucagon like peptide 1 agonistEli lilly and co

Structure Therapeutics And Its Unstructured Weight Loss Data (NASDAQ:GPCR)

Structure Therapeutics And Its Unstructured Weight Loss Data (NASDAQ:GPCR)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Eli lillyStructure therapeutics incIdiopathic pulmonary fibrosisStructure therapeutics